aTYR PHARMA INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.2M | $62.8M | $38.4M |
| FY2017 | $14.7M | $64.2M | $21.1M |
| FY2018 | $8.3M | $33.7M | $23.0M |
| FY2019 | — | $21.2M | $9.2M |
| FY2020 | — | $31.7M | $17.0M |
| FY2021 | — | $109.3M | $2.3M |
| FY2022 | — | $71.5M | $10.0M |
| FY2023 | — | $90.7M | $22.5M |
| FY2024 | — | $70.0M | $11.1M |
| FY2025 | — | $67.5M | $10.7M |